扩散加权成像在婴儿胆汁淤积中鉴别胆道闭锁及评估肝纤维化分级的价值
本回顾性队列研究纳入2009年7月至2017年10月因胆汁淤积行肝脏MRI的227例婴儿,比较胆道闭锁组与非胆道闭锁组的肝脏ADC值、肝/脾ADC比值、APRI及脾脏大小,并用ROC曲线分析各参数对显著纤维化(F3-4)的诊断效能。结果显示肝脏ADC值对胆道闭锁诊断特异度为80.4%,ADC比值敏感度为88.0%,各参数与纤维化分级有显著相关,但对显著纤维化的预测效能有限。
要点
- 肝脏ADC值诊断胆道闭锁特异度80.4%,ADC比值敏感度88.0%,两者诊断效能相当。
- 预测显著纤维化(F3-4)的截断值:APRI 0.783(AUC 0.721)、脾脏大小5.9 cm(AUC 0.719)、肝脏ADC 1.044×10⁻³ mm²/s(AUC 0.673)、ADC比值1.22(AUC 0.651)。
- APRI、脾脏大小、肝脏ADC及ADC比值均与纤维化分级显著相关(均p<0.001)。
关键影像表现/征象
- 两名阅片者间肝脏和脾脏的ADC绝对值差异均为0.10 mm²/s。
- 纤维化分级分布:F0期33例,F1期15例,F2期71例,F3期35例,F4期11例。
诊断标准与关键数值
- 肝脏ADC值诊断胆道闭锁的特异度为80.4%。
- ADC比值诊断胆道闭锁的敏感度为88.0%。
- 预测显著纤维化(F3-4)的截断值:APRI 0.783(AUC 0.721)、脾脏大小5.9 cm(AUC 0.719)、肝脏ADC 1.044×10⁻³ mm²/s(AUC 0.673)、ADC比值1.22(AUC 0.651)。
临床应用与阅片要点
- 肝脏ADC值及ADC比值可作为鉴别胆道闭锁与预测显著纤维化的辅助指标,但附加诊断效能有限。
- APRI与脾脏大小预测显著纤维化的AUC(分别为0.721和0.719)高于肝脏ADC(0.673)及ADC比值(0.651)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To determine whether the values of hepatic apparent diffusion coefficient (ADC) can differentiate biliary atresia (BA) from non-BA or be correlated with the grade of hepatic fibrosis in infants with cholestasis.
MATERIALS AND METHODS: This retrospective cohort study included infants who received liver MRI examinations to evaluate cholestasis from July 2009 to October 2017. Liver ADC, ADC ratio of liver/spleen, aspartate aminotransferase to platelet ratio index (APRI), and spleen size were compared between the BA and non-BA groups. The diagnostic performances of all parameters for significant fibrosis (F3-4) were obtained by receiver-operating characteristics (ROCs) curve analysis.
RESULTS: Altogether, 227 infants (98 males and 129 females, mean age = 57.2 ± 36.3 days) including 125 BA patients were analyzed. The absolute ADC difference between two reviewers was 0.10 mm²/s for both liver and spleen. Liver ADC value was specific (80.4%) and ADC ratio was sensitive (88.0%) for the diagnosis of BA with comparable performance. There were 33 patients with F0, 15 with F1, 71 with F2, 35 with F3, and 11 with F4. All four parameters of APRI (τ= 0.296), spleen size (τ= 0.312), liver ADC (τ= -0.206), and ADC ratio (τ= -0.288) showed significant correlation with fibrosis grade (all, p < 0.001). The cutoff values for significant fibrosis (F3-4) were 0.783 for APRI (area under the ROC curve [AUC], 0.721), 5.9 cm for spleen size (AUC, 0.719), 1.044 × 10-3 mm²/s for liver ADC (AUC, 0.673), and 1.22 for ADC ratio (AUC, 0.651).
CONCLUSION: Liver ADC values and ADC ratio of liver/spleen showed limited additional diagnostic performance for differentiating BA from non-BA and predicting significant hepatic fibrosis in infants with cholestasis.
引用
- Kim J, Shin HJ, Yoon H, et al. Diffusion-Weighted Imaging for Differentiation of Biliary Atresia and Grading of Hepatic Fibrosis in Infants with Cholestasis. Korean J Radiol. 2020. PMID: 32901459. doi:10.3348/kjr.2020.0055
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。